Showing results (261-270 of 282) with videos related to
Sort By:
Pageof 29
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2022
Disclosing the antitumour potential of the marine bromoditerpene sphaerococcenol A on distinct cancer cellular modelsCelso Alves, Joana Silva, Marta B Afonso, et al.Molecular and Cellular Biochemistry|October 6, 2016
Lymphocyte genotoxicity and protective effect of Calyptranthes tricona (Myrtaceae) against H2O2-induced cell death in MCF-7 cellsDébora Mara Kich, Shanna Bitencourt, Bruna Caye, et al.Oncotarget|March 24, 2016
Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cellsCristina Florean, Michael Schnekenburger, Jin-Young Lee, et al.Cell Death & Disease|February 9, 2020
Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemiaSungmi Song, Jin-Young Lee, Ludmila Ermolenko, et al.Clinical Epigenetics|July 16, 2025
Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemiaHaeun Yang, Vladimir Li, Su Jung Park, et al.Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.The Journal of Organic Chemistry|December 4, 2013
Pro-apoptotic and immunostimulatory tetrahydroxanthone dimers from the endophytic fungus Phomopsis longicollaDavid Rönsberg, Abdessamad Debbab, Attila Mándi, et al.Plos One|May 10, 2014
Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activityDante Rotili, Domenico Tarantino, Biagina Marrocco, et al.Biomarker Research|May 4, 2024
Antileukemic potential of methylated indolequinone MAC681 through immunogenic necroptosis and PARP1 degradationBarbora Orlikova-Boyer, Anne Lorant, Sruthi Reddy Gajulapalli, et al.Journal of Medicinal Chemistry|May 6, 2017
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell LinesMichael Schnekenburger, Eric Goffin, Jin-Young Lee, et al.Pageof 29